Global Pharmacovigilance Market Forecast 2018-2028

Tuesday, January 9, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, January 9, 2018 /PRNewswire/ --

US, Japan,

Germany, the UK, France, Italy, Spain, Brazil, Russia,
India, China, South Korea, National Pharmacovigilance Systems, Leading Companies, Trends

The global pharmacovigilance market is expected to grow at a CAGR of 4.8% in the first half of the forecast period. The pharmacovigilance market is estimated to reach $ 11.5bn in 2023.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. 

In this brand new 150-page report you will receive 47 tables and 61 figures- all unavailable elsewhere. 

The 150-page report provides clear detailed insight into the global pharmacovigilance market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Pharmaceutical R&D Spending forecasts from 2017-2028

• Global Pharmacovigilance market forecasts from 2017-2028

• This report provides individual revenue forecasts to 2027 for these regional and national markets: - US - Japan - EU: Germany, France, the UK, Italy, Spain, Others - BRIC: Brazil, Russia, India, China  - South Korea - Others

• This report provides a SWOT and STEP Analysis of the pharmacovigilance market. This report also discusses the Drivers and Restraints of the pharmacovigilance market.

• Our study discusses the selected leading companies that are the major players in the pharmacovigilance market: - Accenture PLC - Cognizant Technology Solutions Corporation - Tata Consultancy Services (TCS) - Capgemini SE - Tech Mahindra Limited - Infosys Limited (Infosys) - Wipro Limited (Wipro) - Oracle Corporation (Oracle) - Bristol-Myers Squibb Company  - HCL Technologies Ltd. - Olympus Corporation

• Moreover, this report discusses the following: - Reporting systems for adverse drug reactions (ADRs) - their present and future, including data on reported and recorded events by year and region - Safety monitoring using reporting from social media  - Improvements in data collection and communication leading to more-flexible drug approval processes - changing routes of marketing authorization - Policies of national and international bodies, and regulators' roles in present and future pharmacovigilance plans - Collaboration between the FDA and EMA, and application of pharmacogenomics and biomarkers - Use of electronic health record (EHR) systems - a live model for drug safety, applying information systems.

Visiongain's study is intended for anyone requiring commercial analyses for the global pharmacovigilance market. You find data, trends and predictions. 

Buy our report today Global Pharmacovigilance Market Forecast 2018-2028: US, Japan, Germany, the UK, France, Italy, Spain, Brazil, Russia, India, China, South Korea, National Pharmacovigilance Systems, Leading Companies, Trends.

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com (+44-(0)-20-7336-6100) or refer to our website:

https://www.visiongain.com/Report/2095/Global-Pharmacovigilance-Market-Forecast-2018-2028

List of Companies Mentioned in the Report 

Abbott Laboratories

Accenture

Accovion

Actavis

Aprova

Aptiv Solutions

Aris Global

AstraZeneca

Bayer

Bristol-Myers Squibb

Capgemini

Cognizant Technology Solutions

Covance

Crossoak Pharma

Crown Consultants

CSO Pharma Consulting

DADA Consultancy

Dose Spot

Drug Safety Alliance

Dun & Bradstreet

Eli Lilly

Epidemico

Facebook

First Databank

Foresight Group International

Forest Laboratories

GB Pharma

Geneix

GlaxoSmithKline (GSK)

Handle My Health

Harten Group

HCL Technologies

ICON

iGATE Corporation

Illumina

iMED Global

Imperial Chemical Industries

INC Research

Infosys

inVentiv Health

IPM Safety Services

Johnson & Johnson

Kinapse

Lindeq

Mahindra Satyam

MedImmune

Merck & Co.

Merck Serono

NDA Group

Nhumi Technologies

Novartis

November Research Group

Novo Nordisk

Optum

Oracle

Orbis Clinical

ParagonRX

Parexel

PatientsLikeMe

Patni Computer Systems

Paul Ehrlich Institute

Pfizer

PharSafer

PPD

PRA International

Primevigilance

Quanticate

Quantum Solutions India

Quintiles Transnational

Ranbaxy

Roche

Sanofi

Sciformix

Servier

SGS Life Sciences

Sun Pharmaceuticals

Symogen

Synowledge

TAKE Solutions

Tata Consultancy Services

Tech Mahindra

Twitter

UDG Healthcare

uMotif

Unified Health System

United Biosource Company

Uppsala Monitoring Centre (UMC))

Warner Chilcott

Watson

Wipro Limited

Wockhardt

Xendo

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

SOURCE Visiongain



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store